-

Landmark Olson Grimsley Premature Infant Formula Case Earns Place in Law.com’s Top 100 Verdicts of 2024

$60 million verdict in baby’s death recognized by VerdictSearch

DENVER--(BUSINESS WIRE)--Olson Grimsley has earned a place on Law.com’s Top 100 Verdicts of 2024 for its groundbreaking $60 million trial victory against Mead Johnson Nutrition, the manufacturer of Enfamil Premature Formula.

On March 13, 2024, the company was found liable for negligence and failing to warn of the risk that its cow’s milk-based formula could cause necrotizing enterocolitis (NEC) in premature infants.

A St. Clair, Ill., jury returned the verdict after less than two hours of deliberation, awarding plaintiff Jasmine Watson $60 million for the loss of her baby, Chance Dean, to NEC.

“This case was about obtaining justice for Jasmine, who will never get her son back,” said Olson Grimsley partner Sean Grimsley, who led the trial team. “It was also about holding Mead Johnson and other companies accountable for their negligence so that no other family has to endure what the Watsons went through.”

The trial was the first among hundreds of lawsuits nationwide claiming the formula caused NEC, an intestinal disease that affects mostly premature babies.

The Olson Grimsley trial team of Mr. Grimsley, partner Kenzo Kawanabe, partner Abby Hinchcliff, associate Samara Hoose and litigation manager Beth Costner served as lead trial counsel, partnering with Ben Whiting and Amelia Frankel of Keller Postman LLC and Dave Cates of The Cates Law Firm, LLC.

Law.com’s Top 100 Verdicts are compiled by VerdictSearch, which ranks verdicts by gross award calculated by the jury. To view the full list, click here.

The case was Watson, et al. v. Mead Johnson & Co. LLC, Case No. 2021L001032 in the Circuit Court of the 20th Judicial District in St. Clair County, Illinois.

About Olson Grimsley

Olson Grimsley Kawanabe Hinchcliff & Murray LLC is a national law firm headquartered in Denver, with the mission of holding the powerful to account. Before founding the firm, the team of talented litigators handled some of the country’s most significant civil rights, antitrust, mass tort, consumer, intellectual property, and environmental cases in courthouses from California to New York, and from rural Arkansas to the U.S. Supreme Court. They are now focusing their expertise on advocating for clients in their most consequential trials and appeals nationwide. More: olsongrimsley.com.

Contacts

April Cadena
april@androvett.com
800-559-4534

Olson Grimsley


Release Versions

Contacts

April Cadena
april@androvett.com
800-559-4534

More News From Olson Grimsley

Three Olson Grimsley Partners Named to 2026 Lawdragon 500 X – The Next Generation Guide

DENVER--(BUSINESS WIRE)--Olson Grimsley Kawanabe Hinchcliff & Murray LLC is pleased to announce that partners Isabel Broer, Jason C. Murray and Bianca Miyata have been selected for the 2026 Lawdragon 500 X – The Next Generation guide, which recognizes rising leaders shaping the future of the legal profession. Ms. Broer was selected for her achievements in civil rights, antitrust and mass torts. Mr. Murray was recognized for commercial litigation, with a focus on antitrust and intellectual p...

Olson Grimsley Partners Earn Top Honors in Chambers USA 2026 Rankings

DENVER--(BUSINESS WIRE)--Olson Grimsley is pleased to announce it has once again been selected among Colorado’s top litigation firms by Chambers USA, with five partners ranked among the state’s best by the prestigious legal guide. The firm received a Band 1 rating, the highest possible, in Colorado for its litigation work primarily on behalf of plaintiffs. Partners Eric Olson, Kenzo Kawanabe and Sean Grimsley also earned individual Band 1 ratings, and partners Jason Murray and Abigail Hinchclif...

Illinois Jury Awards Four Families $70 Million in Verdict Against Baby Formula Manufacturer

CHICAGO--(BUSINESS WIRE)--A Cook County jury has returned a verdict of $70 million including $17 million in punitive damages against Abbott Laboratories, the manufacturer of the cow’s milk-based infant feeding product Similac. The jury found that Abbott’s product caused four premature infants to develop necrotizing enterocolitis (NEC)—a crippling and often fatal intestinal disease. NEC involves the bacterial invasion of a newborn’s intestinal lining, leading to severe inflammation, tissue necro...
Back to Newsroom